바이오테크 보도자료
-
- Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company achieved notable, high scores in all three techni...
- 2021년 01월 27일
-
- Takeda Named Global Top Employer for Fourth Consecutive Year
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receiving the global certification for the fourth conse...
- 2021년 01월 25일
-
- ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
- ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva, the first an...
- 2021년 01월 22일
-
- ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets
- ARTMS Inc. (ARTMS) and Isotopia Molecular Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-11, with over 2 Ci of cyclotron-produced Gallium-68 (68Ga) using ARTMS’ propr...
- 2021년 01월 20일
-
- Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma
- FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY The Mundipharma network of independently associated companies today announced two new appointments to their Executive Committee - Julie Dehaene-Puype as Chief Commercial Officer, Europe and Erik Nordk...
- 2021년 01월 19일
-
- Asia Invests in Biotechnology Innovations to Boost Food Safety, Sustainability
- Asia is actively investing in biotechnology innovations to meet the needs of its rapidly growing population. Calysseo’s FeedKind® single-cell protein project is one such biotechnology innovation that will enhance regional food safety and sustainab...
- 2021년 01월 19일
-
- Asahi Kasei to Build a Second Plant for Ceolus™ Microcrystalline Cellulose
- Asahi Kasei's Specialty Solutions SBU will build a second plant for microcrystalline cellulose [1] (trade name Ceolus™) at its Mizushima Works in Kurashiki, Okayama, Japan. Asahi Kasei currently manufactures Ceolus™, a microcrystalline cellulose u...
- 2021년 01월 14일
-
- Azbil Launches Early Warning System Software Globally
- Azbil Corporation (TOKYO:6845) has announced the global launch of the English and Chinese versions of its Early Warning System for Time Series Data (hereafter, “Early Warning System”) in markets including Southeast Asia, China and Korea. The Early...
- 2021년 01월 14일
-
- Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Of...
- 2021년 01월 14일
-
- ARTMS and Telix Pharmaceuticals Announce Successful Production of PSMA-11 with Cyclotron Produced 68Ga from a Solid Target
- ARTMS Inc. (‘ARTMS’) and Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’) are pleased to announce they have successfully produced Telix’s prostate cancer imaging product, TLX591-CDx (Kit for the preparation of 68Ga-PSMA-11)[1], using multi-Curie ...
- 2021년 01월 13일
전시회
